Methazolamide-derived carbonic anhydrase inhibitors

Details Methazolamide-derived carbonic anhydrase inhibitors Methazolamide-derived carbonic anhydrase inhibitors

1992-10-21

1993-07-06

Lee, Mary C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548139, A61K 3141, C07D285135

Patent

active

052254240

ABSTRACT:
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)ylidene] -2-acetyloxyacetamide, commonly referred to as acetylhydroxymethazolamide and is a water soluble pharmacologically active carbonic anhydrase inhibitor.

REFERENCES:
patent: 4483864 (1984-11-01), Barfknecht et al.
patent: 4483872 (1984-11-01), Barfknecht et al.
patent: 4623664 (1986-11-01), Schoenwald et al.
patent: 4629738 (1986-12-01), Barfknecht et al.
patent: 4636515 (1987-01-01), Barfknecht et al.
patent: 4705798 (1987-11-01), Schoenwald et al.
patent: 4820737 (1989-04-01), Schoenwald et al.
patent: 4866083 (1989-09-01), Schoenwald et al.
patent: 4968718 (1990-11-01), Schoenwald et al.
patent: 4975447 (1990-12-01), Schoenwald et al.
patent: 4975448 (1990-12-01), Schoenwald et al.
patent: 4975449 (1990-12-01), Schoenwald et al.
patent: 5095026 (1992-03-01), Schoenwald et al.
patent: 5104887 (1992-04-01), Schoenwald et al.
patent: 5157044 (1992-10-01), Schoenwald et al.

Affiliated with

Also associated with

Rating

Methazolamide-derived carbonic anhydrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methazolamide-derived carbonic anhydrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methazolamide-derived carbonic anhydrase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1689780